Inari Medical Statistics
Total Valuation
Inari Medical has a market cap or net worth of $3.25 billion. The enterprise value is $3.17 billion.
Important Dates
The last earnings date was Monday, October 28, 2024, after market close.
| Earnings Date | Oct 28, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Inari Medical has 58.54 million shares outstanding. The number of shares has increased by 4.02% in one year.
| Current Share Class | 58.54M |
| Shares Outstanding | 58.54M |
| Shares Change (YoY) | +4.02% |
| Shares Change (QoQ) | +0.39% |
| Owned by Insiders (%) | 8.58% |
| Owned by Institutions (%) | 95.53% |
| Float | 53.49M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 659.46 |
| PS Ratio | 5.60 |
| Forward PS | 4.66 |
| PB Ratio | 7.45 |
| P/TBV Ratio | 41.83 |
| P/FCF Ratio | 604.52 |
| P/OCF Ratio | 228.97 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 5.51 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 589.84 |
Financial Position
The company has a current ratio of 1.77, with a Debt / Equity ratio of 0.08.
| Current Ratio | 1.77 |
| Quick Ratio | 1.32 |
| Debt / Equity | 0.08 |
| Debt / EBITDA | n/a |
| Debt / FCF | 6.09 |
| Interest Coverage | -106.01 |
Financial Efficiency
Return on equity (ROE) is -17.72% and return on invested capital (ROIC) is -4.20%.
| Return on Equity (ROE) | -17.72% |
| Return on Assets (ROA) | -3.21% |
| Return on Capital (ROIC) | -4.20% |
| Revenue Per Employee | $441,922 |
| Profits Per Employee | -$60,448 |
| Employee Count | 1,300 |
| Asset Turnover | 0.92 |
| Inventory Turnover | 1.59 |
Taxes
In the past 12 months, Inari Medical has paid $25.23 million in taxes.
| Income Tax | 25.23M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -15.30% in the last 52 weeks. The beta is 0.97, so Inari Medical's price volatility has been similar to the market average.
| Beta (5Y) | 0.97 |
| 52-Week Price Change | -15.30% |
| 50-Day Moving Average | 49.93 |
| 200-Day Moving Average | 46.75 |
| Relative Strength Index (RSI) | 58.83 |
| Average Volume (20 Days) | 1,170,269 |
Short Selling Information
The latest short interest is 2.92 million, so 4.98% of the outstanding shares have been sold short.
| Short Interest | 2.92M |
| Short Previous Month | 3.42M |
| Short % of Shares Out | 4.98% |
| Short % of Float | 5.45% |
| Short Ratio (days to cover) | 3.32 |
Income Statement
In the last 12 months, Inari Medical had revenue of $574.50 million and -$78.58 million in losses. Loss per share was -$1.35.
| Revenue | 574.50M |
| Gross Profit | 498.76M |
| Operating Income | -32.02M |
| Pretax Income | -35.09M |
| Net Income | -78.58M |
| EBITDA | -26.13M |
| EBIT | -32.02M |
| Loss Per Share | -$1.35 |
Full Income StatementBalance Sheet
The company has $111.54 million in cash and $32.72 million in debt, giving a net cash position of $78.81 million or $1.35 per share.
| Cash & Cash Equivalents | 111.54M |
| Total Debt | 32.72M |
| Net Cash | 78.81M |
| Net Cash Per Share | $1.35 |
| Equity (Book Value) | 434.76M |
| Book Value Per Share | 7.44 |
| Working Capital | 114.61M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $14.18 million and capital expenditures -$8.81 million, giving a free cash flow of $5.37 million.
| Operating Cash Flow | 14.18M |
| Capital Expenditures | -8.81M |
| Free Cash Flow | 5.37M |
| FCF Per Share | $0.09 |
Full Cash Flow StatementMargins
Gross margin is 86.82%, with operating and profit margins of -5.57% and -13.68%.
| Gross Margin | 86.82% |
| Operating Margin | -5.57% |
| Pretax Margin | -9.29% |
| Profit Margin | -13.68% |
| EBITDA Margin | -4.55% |
| EBIT Margin | -5.57% |
| FCF Margin | 0.93% |
Dividends & Yields
Inari Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -4.02% |
| Shareholder Yield | -4.02% |
| Earnings Yield | -2.42% |
| FCF Yield | 0.17% |
Dividend DetailsAnalyst Forecast
The average price target for Inari Medical is $62.33, which is 12.41% higher than the current price. The consensus rating is "Buy".
| Price Target | $62.33 |
| Price Target Difference | 12.41% |
| Analyst Consensus | Buy |
| Analyst Count | 11 |
| Revenue Growth Forecast (5Y) | 17.15% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Inari Medical has an Altman Z-Score of 7.43 and a Piotroski F-Score of 3.
| Altman Z-Score | 7.43 |
| Piotroski F-Score | 3 |